unknown
Stage
2020
Founded
2
Investors
About
Complement Therapeutics is a biotechnology company focused on developing therapies that target components of the complement system to treat inflammatory and autoimmune diseases.
Explore Complement Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.